Major Companies Leading the Hyperhidrosis Market
Some of the prominent companies operating in the hyperhidrosis treatment space include Botanix Pharmaceuticals, GSK Plc, Allergan, Brickell Biotech, Atacama Therapeutics, TheraVida, Revance, NovaMedica, Ulthera, DEMIRA e.V, AbbVie, Fresh Tracks Therapeutics, Dr. August Wolff GmbH, Dermavant Sciences, Eirion Therapeutics, Kaken Pharmaceutical Co., Ltd., Intas Pharmaceuticals, Roivant Sciences Ltd. and others.
Overview of the hyperhidrosis treatment market
(Albany, USA)– DelveInsight's latest report,"Hyperhidrosis – Market Insights, Epidemiology, and Market Forecast – 2032"It provides a comprehensive analysis of the hyperhidrosis market across the US, EU5 (Germany, France, Italy, Spain, UK), and Japan. The study includes historical and projected epidemiological data, emerging treatment options, and evolving market dynamics.
The report outlines current therapeutic practices, detailed drug profiles, market shares and forecast market size from 2019 to 2032. Opportunities are identified by analysing market drivers, barriers and unmet needs, and actionable insights are provided.
📩 Get a free sample of the report here:Hyperhidrosis Market ForecastSample
Highlights of the Hyperhidrosis Market Report:
- DelveInsight predicts that by 2032, the hyperhidrosis market size will witness a healthy CAGR.
- Notable new treatments include:Botox、 BBI-4000 (Sofibronium bromide)、 THVD-102、 Umeclizine、 AT-5214,others.
- In October 2024,Dryox HealthShares positive Phase 2 results forVictoryFor severe palmar hyperhidrosis.
- In June 2024,Botanix PharmaceuticalsFDA ApprovedSoftora, a topical anticholinergic agent for primary axillary hyperhidrosis in patients aged 9 years and older.
- In May 2023, Botanix also began a clinical study evaluating three different concentrations.BBI-4000。
- In April 2023, a clinical study used the starch iodine test to evaluate the effectiveness of antiperspirants on residual limb sweating.
Hyperhidrosis: An Overview
Hyperhidrosis refers to abnormally excessive sweating that exceeds the physiological need for thermoregulation. It can affect specific body areas such as the palms of the hands, soles of the feet, armpits, and face.Primary hyperhidrosisIt is often idiopathic and hereditary, whereasSecondary hyperhidrosisIt may be due to an underlying medical condition or medication. The condition can affect quality of life and cause psychological distress. Treatments range from topical and oral medications to Botox injections, iontophoresis, and even surgical interventions such as sympathectomy.
📩 Explore local treatment patterns and patient outcomes: Request a sample –Hyperhidrosis Treatment Market
Market dynamics:
The report details:
- The impact of current treatment practices
- Market limitations and growth drivers
- Evaluating evolving technologies and clinical advances
Each marketed and pipeline drug is evaluated based on annual cost of treatment, target population, launch timeline, drug mechanism, compliance, competition, and brand value.
📊 The 7MM Hyperhidrosis market is expected to undergo significant evolution between 2019 and 2032.
Epidemiology insights:
This section provides more information about:
- Overall prevalence and incidence of 7MM
- Analysis of diagnosed and treatable populations
- Expert-validated past and future trends
📈 Learn more about epidemiological trends –Prevalence of hyperhidrosis data
Drug intake and sales forecast
In this section we analyze:
- Trends in uptake of recently launched and upcoming treatments
- Comparison of pharmaceutical performance in terms of market share and adoption
- High patient uptake rates and insight into key sales drivers
📈 Understanding Market Penetration – Hyperhidrosis Medication Uptake Analysis
Pipeline Development
It covers therapeutics in clinical development (Phase II and III) and offers:
- Mechanism of action
- Clinical trial progress
- Major sponsors and partnerships
To understand more about the Hyperhidrosis pipeline development activities, request a sample report @Clinical Trials and Treatment Advances for Hyperhidrosis
Perspectives on treatment
Large companies such asBotanics、 Allergan、 Seravida、 AbbVie、 Dermavant, and Fresh Tracks Therapeuticsis investing in new formulations and delivery technologies to fulfill current unmet needs in the market.
📌 Stay up to date on new treatments – VisitHyperhidrosis Treatment Market
Report highlights:
- Epidemiology of hyperhidrosis
- Market size and future outlook
- Key Competitor Analysis
- Market Growth Drivers and Barriers
- Pipeline Innovation
- Evolving Treatment Algorithms
- Key opinions and forecast assumptions of KOLs
- Reimbursement and Market Access Scenarios
table of contents
- Key Takeaways
- executive summary
- Competitive Environment
- Market Snapshot
- Overview of Disease
- The patient journey
- Epidemiology Forecast (7MM)
- Treatment Algorithms and Practices
- Unmet needs
- Treatment endpoints
- Overview of commercially available products
- Evaluating Pipeline Therapies
- 7MM Market Analysis
- Drug Attribute Evaluation
- Market Outlook
- Access and reimbursement status
- KOL Insights
- Market Drivers
- Market Challenges
- appendix
- About DelveInsight
- Disclaimer
About DelveInsight
DelveInsight is a leading healthcare market research and business consulting firm, recognized for its expertise in delivering actionable insights through syndicated reports and custom research solutions for the pharmaceutical and biotechnology industries.
English
Dutch